midazolam has been researched along with Central Nervous System Diseases in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sequelae and risk for recurrence of SE are primarily related to the underlying cause." | 2.39 | Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. ( Mitchell, WG, 1996) |
| "Midazolam is a broadly used drug that can enhance tolerance to transesophageal echocardiography (TEE) in patients with cardiac conditions." | 1.31 | Central-nervous side effects of midazolam during transesophageal echocardiography. ( Bartel, T; Eggebrecht, H; Erbel, R; Philipp, T; Wenzel, RR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamijo, Y | 1 |
| Wenzel, RR | 1 |
| Bartel, T | 1 |
| Eggebrecht, H | 1 |
| Philipp, T | 1 |
| Erbel, R | 1 |
| McCartney, CJ | 1 |
| Murphy, DB | 1 |
| Iagounova, A | 1 |
| Chan, VW | 1 |
| Cohen, S | 1 |
| Hunter, CW | 1 |
| Yanni, B | 1 |
| Striker, P | 1 |
| Hijazi, RH | 1 |
| Mitchell, WG | 1 |
2 reviews available for midazolam and Central Nervous System Diseases
| Article | Year |
|---|---|
[Dangerous drugs: products containing synthetic chemicals].
Topics: Alkaloids; Antipsychotic Agents; Cannabinoids; Central Nervous System Diseases; Consciousness Disord | 2016 |
Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Benzodiazepines; Central Nervous System Disea | 1996 |
1 trial available for midazolam and Central Nervous System Diseases
| Article | Year |
|---|---|
Intravenous ropivacaine bolus is a reliable marker of intravascular injection in premedicated healthy volunteers.
Topics: Adjuvants, Anesthesia; Adult; Amides; Anesthesia, Conduction; Anesthetics, Local; Blood Pressure; Ce | 2003 |
2 other studies available for midazolam and Central Nervous System Diseases
| Article | Year |
|---|---|
Central-nervous side effects of midazolam during transesophageal echocardiography.
Topics: Adult; Aged; Anesthetics, Intravenous; Central Nervous System Diseases; Dose-Response Relationship, | 2002 |
Central anticholinergic syndrome strikes again.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, General; Anesthetics, Intravenous; Central Nervous System | 2006 |